Prostatic duct adenocarcinoma. Findings at radical prostatectomy

Area of Science:

• Urology
• Oncology
• Pathology

Background:

• Prostatic duct adenocarcinoma (PDA) has a poorly understood prognosis, particularly in patients treated with radical prostatectomy.
• Previous studies lacked sufficient cases undergoing radical prostatectomy, limiting understanding of PDA's pathological features and clinical outcomes.

Purpose of the Study:

• To define the pathological features of PDA in patients treated with radical prostatectomy.
• To determine the clinical outcome of PDA following radical prostatectomy.
• To compare PDA characteristics and outcomes with acinar prostate cancer.

Main Methods:

• Retrospective analysis of 15 PDA cases treated with radical prostatectomy.
• Inclusion of morphometry and DNA image analysis using the CAS-200 system.
• Clinical follow-up to assess tumor recurrence and persistence.

Main Results:

• PDA commonly presented with urinary outlet obstruction and clinical Stage B disease.
• Tumors were large, occupied a significant portion of the gland, and frequently showed advanced pathological features (capsular penetration, positive margins, seminal vesicle invasion, lymph node metastasis).
• 47% of patients experienced tumor persistence within 3-18 months post-surgery, indicating a high short-term failure rate.

Conclusions:

• Prostatic duct adenocarcinoma presents at an advanced pathological stage.
• PDA has a significantly higher short-term failure rate after radical prostatectomy compared to acinar prostate cancer.
• These findings highlight the aggressive nature of PDA and the need for tailored treatment strategies.